EE4 Cost-Effectiveness of Andexanet Alfa Versus Prothrombin Complex Concentrate Is Likely for the Treatment of Factor Xa Inhibitor–Related Major Bleeds in the Netherlands
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.277
https://www.valueinhealthjournal.com/article/S1098-3015(23)03407-1/fulltext
Title :
EE4 Cost-Effectiveness of Andexanet Alfa Versus Prothrombin Complex Concentrate Is Likely for the Treatment of Factor Xa Inhibitor–Related Major Bleeds in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03407-1&doi=10.1016/j.jval.2023.09.277
First page :
Section Title :
Open access? :
No
Section Order :
12035